|
Continuation of d10: product id: 37602, lot# serial# (b)(6), implanted: (b)(6) 2022, product type: implantable neurostimulator.Product id: 3387-40, lot# (b)(6) serial #, implanted: (b)(6) 2002.Product type: lead.Product id: 748251, lot# serial# (b)(6), implanted: (b)(6) 2002, product type: extension.Section d information references the main component of the system.Other relevant device(s) are: product id: 3387-40, serial/lot #:(b)(6), ubd: 01-mar-2006, udi#: (b)(4).Product id: 748251, serial/lot #: (b)(6), ubd: 24-apr-2006, udi#: (b)(4).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Additional information was received from the manufacturer representative (rep) that during replacement of right side implantable neurostimulator (ins), impedance within normal limits pre op.During replacement, impedances on contact 0 and 3 were low as occurred in original event in 2022.These contacts are not being used for therapy; thus no additional actions are planned.
|